In a milestone achievement for oncology, the biopharma giant GSK’s Jemperli cancer drug trial has met positive interim Phase II results from …
The University of Oxford has officially launched the world’s first Phase I clinical trial of a vaccine specifically targeting the Bundibugyo ebolavirus. …
The Grattan Institute has released a landmark report, Future Pharmacy: A Better Deal for Patients and Taxpayers. This report on Australian Pharmacy …
A crusted scabies infection, a highly contagious form of scabies, has spread in Glangwili Hospital in Carmarthen, Wales, triggering an immediate public …
The U.S. Food and Drug Administration (FDA) has announced a major, nationwide Class II recall involving more than 2.53 million prescription eye …
The British drugmaker AstraZeneca announced that its late-stage clinical trial evaluating Wainua for a rare heart condition failed to meet its primary …
Danish pharmaceutical giant Novo Nordisk has officially identified Australia as a high-priority global market for its highly anticipated weight loss pill Wegovy. …
China’s Sino Biopharmaceutical has secured two massive international agreements with AstraZeneca and GSK for respiratory medicine. With the Sino Biopharmaceutical respiratory drug …
In a major milestone for chronic kidney disease treatment, Vera’s Trutakna drug gets FDA approval as a weekly injectable kidney drug. Manufactured …
In a breakthrough in early endometriosis diagnosis, researchers from the University of Edinburgh have identified hormone biomarkers that can detect endometriosis with …
Vertex Pharmaceuticals has announced a definitive agreement to acquire Crinetics Pharmaceuticals for approximately $10 billion, the company’s largest acquisition ever. This massive …
The Swiss pharmaceutical giant Novartis has officially agreed to acquire UK-based biotechnology firm Myricx Bio. The Novartis Myricx Bio acquisition is valued …
In a milestone achievement for oncology, the biopharma giant GSK’s Jemperli cancer drug trial has met positive interim Phase II
The University of Oxford has officially launched the world’s first Phase I clinical trial of a vaccine specifically targeting the
The Grattan Institute has released a landmark report, Future Pharmacy: A Better Deal for Patients and Taxpayers. This report on
A crusted scabies infection, a highly contagious form of scabies, has spread in Glangwili Hospital in Carmarthen, Wales, triggering an
The U.S. Food and Drug Administration (FDA) has announced a major, nationwide Class II recall involving more than 2.53 million
The British drugmaker AstraZeneca announced that its late-stage clinical trial evaluating Wainua for a rare heart condition failed to meet
Danish pharmaceutical giant Novo Nordisk has officially identified Australia as a high-priority global market for its highly anticipated weight loss
China’s Sino Biopharmaceutical has secured two massive international agreements with AstraZeneca and GSK for respiratory medicine. With the Sino Biopharmaceutical
In a major milestone for chronic kidney disease treatment, Vera’s Trutakna drug gets FDA approval as a weekly injectable kidney
In a breakthrough in early endometriosis diagnosis, researchers from the University of Edinburgh have identified hormone biomarkers that can detect
Vertex Pharmaceuticals has announced a definitive agreement to acquire Crinetics Pharmaceuticals for approximately $10 billion, the company’s largest acquisition ever.
The Swiss pharmaceutical giant Novartis has officially agreed to acquire UK-based biotechnology firm Myricx Bio. The Novartis Myricx Bio acquisition
